PhaseRx, Inc. (OTCPK: PZRX.Q)
Health Care · Biotechnology · US
$—
— today · — 1Y
PhaseRx, Inc. (OTCPK: PZRX.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.00.
trading between 0.00 and 0.00.
Tweenvest scores PhaseRx, Inc. across four factors: quality 13/100. Its strongest factor is quality.
PZRX.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.19
- Dividend yield
- —
- Beta (5Y)
- 32.95
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.71M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.66 | +0.64% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.00 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.97 | +0.58% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.19 | +0.03% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $842.16 | +0.97% |
| argenx SEENXTBR: ARGX | $65.85B | €875.60 | -2.93% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $144.51 | -0.39% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.